Free Trial

ResMed (RMD) Competitors

ResMed logo
$245.49 -0.29 (-0.12%)
Closing price 03:59 PM Eastern
Extended Trading
$245.48 -0.01 (0.00%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RMD vs. MDT, BDX, EW, IDXX, DXCM, STE, PODD, BAX, HOLX, and MASI

Should you be buying ResMed stock or one of its competitors? The main competitors of ResMed include Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), DexCom (DXCM), STERIS (STE), Insulet (PODD), Baxter International (BAX), Hologic (HOLX), and Masimo (MASI). These companies are all part of the "health care equipment" industry.

ResMed vs.

ResMed (NYSE:RMD) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, community ranking, analyst recommendations, earnings, risk, profitability and media sentiment.

Medtronic received 1153 more outperform votes than ResMed when rated by MarketBeat users. Likewise, 75.40% of users gave Medtronic an outperform vote while only 52.71% of users gave ResMed an outperform vote.

CompanyUnderperformOutperform
ResMedOutperform Votes
438
52.71%
Underperform Votes
393
47.29%
MedtronicOutperform Votes
1591
75.40%
Underperform Votes
519
24.60%

ResMed presently has a consensus price target of $258.83, indicating a potential upside of 5.44%. Medtronic has a consensus price target of $96.07, indicating a potential upside of 18.70%. Given Medtronic's higher probable upside, analysts clearly believe Medtronic is more favorable than ResMed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ResMed
1 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.60
Medtronic
1 Sell rating(s)
8 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.47

ResMed has a net margin of 25.34% compared to Medtronic's net margin of 12.83%. ResMed's return on equity of 26.17% beat Medtronic's return on equity.

Company Net Margins Return on Equity Return on Assets
ResMed25.34% 26.17% 18.60%
Medtronic 12.83%14.07%7.70%

55.0% of ResMed shares are held by institutional investors. Comparatively, 82.1% of Medtronic shares are held by institutional investors. 0.7% of ResMed shares are held by insiders. Comparatively, 0.2% of Medtronic shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

ResMed pays an annual dividend of $2.12 per share and has a dividend yield of 0.9%. Medtronic pays an annual dividend of $2.80 per share and has a dividend yield of 3.5%. ResMed pays out 23.8% of its earnings in the form of a dividend. Medtronic pays out 85.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. ResMed has raised its dividend for 13 consecutive years and Medtronic has raised its dividend for 48 consecutive years. Medtronic is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Medtronic had 26 more articles in the media than ResMed. MarketBeat recorded 68 mentions for Medtronic and 42 mentions for ResMed. ResMed's average media sentiment score of 1.22 beat Medtronic's score of 0.83 indicating that ResMed is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ResMed
31 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Medtronic
32 Very Positive mention(s)
5 Positive mention(s)
20 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive

Medtronic has higher revenue and earnings than ResMed. Medtronic is trading at a lower price-to-earnings ratio than ResMed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ResMed$5.02B7.17$1.02B$8.9127.55
Medtronic$33.20B3.13$3.68B$3.2924.60

ResMed has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500.

Summary

ResMed beats Medtronic on 11 of the 21 factors compared between the two stocks.

Get ResMed News Delivered to You Automatically

Sign up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RMD vs. The Competition

MetricResMedSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$36.00B$4.43B$5.33B$19.30B
Dividend Yield0.84%43.63%5.21%3.84%
P/E Ratio28.9829.0826.7134.53
Price / Sales7.1766.76386.1334.83
Price / Cash25.2351.0838.2517.51
Price / Book6.866.196.774.69
Net Income$1.02B$67.60M$3.23B$1.02B
7 Day Performance-1.25%-0.63%1.80%-1.74%
1 Month Performance14.50%17.91%11.10%7.50%
1 Year Performance12.47%21.16%17.11%4.15%

ResMed Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RMD
ResMed
4.1128 of 5 stars
$245.49
-0.1%
$258.83
+5.4%
+12.5%$36.00B$5.02B28.988,160Positive News
Insider Trade
Analyst Revision
MDT
Medtronic
4.7737 of 5 stars
$86.78
+0.4%
$96.14
+10.8%
-0.8%$111.30B$33.20B26.3895,000Trending News
Earnings Report
Dividend Increase
Analyst Forecast
Options Volume
BDX
Becton, Dickinson and Company
4.9803 of 5 stars
$176.33
+0.5%
$231.44
+31.3%
-26.2%$50.54B$20.87B29.2977,000Positive News
Analyst Forecast
EW
Edwards Lifesciences
4.3624 of 5 stars
$77.98
0.0%
$79.60
+2.1%
-15.7%$45.74B$5.52B11.1917,300Positive News
Analyst Forecast
Insider Trade
IDXX
IDEXX Laboratories
3.4005 of 5 stars
$519.35
+0.2%
$536.00
+3.2%
-3.4%$41.77B$3.93B48.6710,800News Coverage
Positive News
Analyst Forecast
DXCM
DexCom
4.7397 of 5 stars
$86.72
+1.5%
$98.11
+13.1%
-35.1%$34.00B$4.15B60.647,600Positive News
Analyst Forecast
STE
STERIS
4.5557 of 5 stars
$251.48
0.0%
$264.00
+5.0%
+6.8%$24.71B$5.40B53.3916,000News Coverage
Analyst Forecast
PODD
Insulet
4.4384 of 5 stars
$325.30
+0.2%
$306.53
-5.8%
+77.5%$22.89B$2.20B56.182,600Positive News
Analyst Forecast
BAX
Baxter International
4.6541 of 5 stars
$31.36
-0.9%
$37.25
+18.8%
-11.7%$16.09B$10.77B-24.5060,000
HOLX
Hologic
4.9554 of 5 stars
$56.29
-0.9%
$77.42
+37.5%
-26.5%$12.54B$4.03B17.766,940Positive News
MASI
Masimo
4.8502 of 5 stars
$154.54
-0.7%
$191.60
+24.0%
+20.0%$8.38B$2.13B106.586,200Positive News

Related Companies and Tools


This page (NYSE:RMD) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners